We have reported that Delta-24-RGDOX, an oncolytic adenovirus expressing immune co-stimulator OX40 ligand (OX40L), induces efficacious anti-glioma immunity in syngeneic intracranial glioma models of immune competent mice. The gene discussed is TNFSF4; the disease is central nervous system cancer.